A bladder cancer-based study reported that miR-21 expression was significantly reduced in formononetin-exposed bladder cancer cells, followed by an increase in PTEN, as well as p-Akt downregulation [39] (Table 1). The gene discussed is AKT1; the disease is urinary bladder cancer.